article thumbnail

Bayer appoints Nelson Ambrogio as new Head of Radiology Business at Pharmaceuticals Division

Imaging Technology

milla1cf Tue, 01/23/2024 - 13:50 January 23, 2024 — Bayer announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals Division, effective April 1, 2024. He will report to Stefan Oelrich , Member of the Board of Management, Bayer AG, and President Pharmaceuticals.

article thumbnail

SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers

Imaging Technology

milla1cf Wed, 10/11/2023 - 13:24 October 11, 2023 — GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE), a Virginia, U.S.-based SOFIE and GE HealthCare will collaborate on both the development and commercialization processes through a joint steering committee. Sherly Mosessian , Ph.D,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

GE HealthCare Closes MIM Software Acquisition

Imaging Technology

milla1cf Tue, 04/02/2024 - 18:51 April 2, 2024 — Less than three months after signing an agreement to acquire MIM Software Inc. , GE HealthCare Technologies Inc. This includes continuing to grow MIM Software’s offerings for end-to-end standardization across large healthcare system fleets.

article thumbnail

GE HealthCare Announces Agreement to Acquire MIM Software

Imaging Technology

GE HealthCare expects to leverage MIM Software’s imaging analytics and digital workflow capabilities across various care areas to accelerate innovation and differentiate its solutions for the benefit of patients and healthcare systems around the world.

article thumbnail

Lawsuit accuses radiology AI vendor MIM Software of patent theft

Radiology Business

Progenics Pharmaceuticals Inc. claims MIM stole its patents and used them to help entice GE HealthCare to buy the company in January.

article thumbnail

Paper Calls for Patient-first Regulation of AI in Healthcare

Imaging Technology

of the Qualcomm Institute within the University of California San Diego , finds that question can be difficult to answer since AI products in healthcare do not universally undergo any externally evaluated approval process assessing how it might benefit patient outcomes before coming to market. A new study published in JAMA led by John W.

article thumbnail

Delphinus names Michael Emery CFO

AuntMinnie

Emery has more than 30 years of experience in financial executive leadership in the pharmaceutical and medical device industries. Prior to that, he led financial executive teams at Plasma Surgical and Abbott Pharmaceuticals. He was previously CFO and chief operating officer (COO) at Tyber Medical.